This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Department of Reproductive Health and Research. Gender and reproductive rights: sexual health. World Health Organization. Available at: http://www.who.int/reproductive-health/gender/sexual_health.html. Accessed November 25, 2003.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.
Althof SE . Quality of life and erectile dysfunction. Urology 2002; 59: 803–810.
Martin-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166: 569–574, discussion 574–575.
Aytaç IA, McKinlay JB, Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–56.
Moncada I, Saenz de Tejada I . Vascular physiology of penile erection. In: Carson C, Kirby R, Goldstein I (eds). Textbook of Erectile Dysfunction. Isis Medical Media: Oxford, 1999, pp 51–57.
Lue TF . Erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.
Moreland RB . Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113–120.
Keene LC, Davies PH . Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999; 18: 5–24.
Burls A, Gold L, Clark W . Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract 2001; 51: 1004–1012.
Fink HA et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002; 162: 1349–1360.
Brock GB et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168: 1332–1336.
Porst H et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001; 13: 192–199.
Hellstrom WJ et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763–771.
Heaton JP . Apomorphine: an update of clinical trial results. Int J Impot Res 2000; 12(Suppl 4): S67–S73.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moncada, I. Document for the general public. Int J Impot Res 16 (Suppl 2), S7–S9 (2004). https://doi.org/10.1038/sj.ijir.3901236
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901236